SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the…
Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) PORTLAND, Maine,…
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021 Conference call and…
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
– Initiated a Phase 1/1b clinical trial for IVX-121, a virus like particle (VLP) vaccine…
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., Nov. 15, 2021…
Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales…
Management to Host Conference Call Today, Monday, November 15, 2021, 5:30 p.m. ET FORT COLLINS,…
Veteran executive previously led Abbott’s global diagnostics organization Kim Popovits, interim chief executive officer, to…
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., Nov. 15, 2021…
Net revenue for third quarter of 2021 increased 123% year-over-year to $21.1 million, a quarterly…
Darrin Miles to Depart Agios to Pursue a Chief Executive Officer Opportunity CAMBRIDGE, Mass., Nov….
WALTHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company…
Positive Updates Announced for Inhaled Voriconazole and Tacrolimus Programs;Both Programs Advancing into Phase 2 Testing…
Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 Expanding and…
Saint–Herblain (France), November 15, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
NYMOX Provides Current Update HASBROUCK HEIGHTS, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) — Nymox Pharmaceutical…
Mechelen, Belgium; 15 November 2021; 16.45 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today…
New publication in Science Advances describes this ambitious initiative to define the chemical diversity of…
CALGARY, Alberta, Nov. 15, 2021 (GLOBE NEWSWIRE) — Zenith Capital Corp. (“Zenith” or the “Company”)…